Silver Wound Dressings Market By Product Type (Sheets, Gels and Creams, Foams, Others), By Treatment (Surgical Wounds, Burns, Ulcers, Lacerations and Cuts, Skin Grafts, Others), By End User (Hospitals and Clinics, Ambulatory Surgical Centers, Homecare): Global Opportunity Analysis and Industry Forecast, 2021-2031
The global silver wound dressings market was valued at $889.1 million in 2021, and is projected to reach $1,511.8 million by 2031, registering a CAGR of 5.4% from 2022 to 2031.Silver wound dressings are antimicrobial dressings, which are integrated with silver. The metal, in ionized form, exhibits enhanced antifungal and antimicrobial properties, and are used in wound dressings for preventing biofilm formation by pathogenic bacteria These dressings are wound care products intended to manage bioburden in acute and chronic wounds. In addition, these dressings provide antimicrobial action on low to high exudates wounds, ulcers, and burns.
The key factors that drive the growth of the market are increase in prevalence of sport related injuries and & road accidents, rise in geriatric population, and surge in number of surgical procedures. For instance, according to International Diabetes Federation, in 2021, approximately 537 million adults (20-79 years) are living with diabetes. The total number of people living with diabetes is projected to rise to 643 million by 2030 and 783 million by 2045. Furthermore, it was estimated that more than 1.2 million children and adolescents (0-19 years) are living with type 1 diabetes and 541 million adults are at increased risk of developing type 2 diabetes.
Moreover, the rise in awareness of the beneficial properties of silver incorporated dressing such as antimicrobial nature, reduction in healing time and lowered infection risks are the key factors boost the growth of the market.
However, the high cost of silver wound care is expected to hinder the growth of the market. On the other hand, rise in geriatric population, increasing awareness towards advanced wound care therapies and high growth optional in developing economies are anticipated to provide lucrative opportunities for the growth of the market during the forecast period.
The silver wound dressings market is segmented on the basis of product type, treatment, end user, and region. By product type, it is categorized into sheets, gel & creams, foams, and others. The gels & creams segment is further classified into alginate, hydrogel, silver sulfadiazine and others. By treatment, the market is categorized into ulcers, skin grafts, lacerations & cuts, surgical wounds, burns, and others. By end user, the market is fragmented into hospital & clinics, ambulatory surgical centers, and homecare. Region-wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
North America accounted for a majority of the silver wound dressings market share in 2021 and is anticipated to remain dominant during the forecast period. The market is mainly driven by the presence of well-established healthcare facilities and a high prevalence rate of diabetes and chronic & acute wounds. Moreover, the presence of a number of key players involved in R&D activities for the development of technologically advanced products is contributing toward the market growth in this region.
Asia-Pacific is expected to register the fastest CAGR during the forecast period. This is due to the presence of large geriatric population and constantly improving healthcare infrastructure. In addition, the rapidly growing population, and increase in number of surgical procedures and road accidents, is set to drive the market growth in the Asia-Pacific region.
The key players that operate in the silver wound dressings market include 3M (Acelity Inc.), Medline Industries, LP, Argentum Medical LLC, B. Braun Melsungen AG, Convatec Inc, Dermarite Industries, Inc, Ferris Mfg. Corp., Ltd., Johnson and Johnson, Molnlycke Health Care AB, and Smith and Nephew PLC.
Key Benefits For Stakeholders
This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the silver wound dressings market analysis from 2021 to 2031 to identify the prevailing silver wound dressings market opportunities.
The market research is offered along with information related to key drivers, restraints, and opportunities.
Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
In-depth analysis of the silver wound dressings market segmentation assists to determine the prevailing market opportunities.
Major countries in each region are mapped according to their revenue contribution to the global market.
Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
The report includes the analysis of the regional as well as global silver wound dressings market trends, key players, market segments, application areas, and market growth strategies.
Key Market Segments
By Product Type
Sheets
Gels and Creams
Type
Alginate
Hydrogel
Silver sulfadiazine
Others
Foams
Others
By Treatment
Surgical Wounds
Burns
Ulcers
Lacerations and Cuts
Skin Grafts
Others
By End User
Hospitals and Clinics
Ambulatory Surgical Centers
Homecare
By Region
North America
U.S.
Canada
Mexico
Europe
Germany
France
UK
Italy
Spain
Rest of Europe
Asia-Pacific
Japan
China
Australia
India
South Korea
Rest of Asia-Pacific
LAMEA
Brazil
Saudi Arabia
South Africa
Rest of LAMEA
Key Market Players
3M Company
Argentum Medical LLC
, B Braun Melsungen AG
Convatec, Inc.
Ferris Mfg.Corp
Johnson And Johnson
Monlycke Health Care
Mölnlycke Health Care
medline industries, inc.
DermaRite Industries, LLC.
Please Note: It will take 7-10 business days to complete the report upon order confirmation.
- CHAPTER 1:INTRODUCTION
- 1.1.Report description
- 1.2.Key market segments
- 1.3.Key benefits to the stakeholders
- 1.4.Research Methodology
- 1.4.1.Secondary research
- 1.4.2.Primary research
- 1.4.3.Analyst tools and models
- CHAPTER 2:EXECUTIVE SUMMARY
- 2.1.Key findings of the study
- 2.2.CXO Perspective
- CHAPTER 3:MARKET OVERVIEW
- 3.1.Market definition and scope
- 3.2.Key findings
- 3.2.1.Top investment pockets
- 3.3.Porter’s five forces analysis
- 3.4.Top player positioning
- 3.5.Market dynamics
- 3.5.1.Drivers
- 3.5.2.Restraints
- 3.5.3.Opportunities
- 3.6.COVID-19 Impact Analysis on the market
- CHAPTER 4: SILVER WOUND DRESSINGS MARKET, BY PRODUCT TYPE
- 4.1 Overview
- 4.1.1 Market size and forecast
- 4.2 Sheets
- 4.2.1 Key market trends, growth factors and opportunities
- 4.2.2 Market size and forecast, by region
- 4.2.3 Market share analysis by country
- 4.3 Gels and Creams
- 4.3.1 Key market trends, growth factors and opportunities
- 4.3.2 Market size and forecast, by region
- 4.3.3 Market share analysis by country
- 4.3.4 Gels and Creams Silver Wound Dressings Market by Type
- 4.4 Foams
- 4.4.1 Key market trends, growth factors and opportunities
- 4.4.2 Market size and forecast, by region
- 4.4.3 Market share analysis by country
- 4.5 Others
- 4.5.1 Key market trends, growth factors and opportunities
- 4.5.2 Market size and forecast, by region
- 4.5.3 Market share analysis by country
- CHAPTER 5: SILVER WOUND DRESSINGS MARKET, BY TREATMENT
- 5.1 Overview
- 5.1.1 Market size and forecast
- 5.2 Surgical Wounds
- 5.2.1 Key market trends, growth factors and opportunities
- 5.2.2 Market size and forecast, by region
- 5.2.3 Market share analysis by country
- 5.3 Burns
- 5.3.1 Key market trends, growth factors and opportunities
- 5.3.2 Market size and forecast, by region
- 5.3.3 Market share analysis by country
- 5.4 Ulcers
- 5.4.1 Key market trends, growth factors and opportunities
- 5.4.2 Market size and forecast, by region
- 5.4.3 Market share analysis by country
- 5.5 Lacerations and Cuts
- 5.5.1 Key market trends, growth factors and opportunities
- 5.5.2 Market size and forecast, by region
- 5.5.3 Market share analysis by country
- 5.6 Skin Grafts
- 5.6.1 Key market trends, growth factors and opportunities
- 5.6.2 Market size and forecast, by region
- 5.6.3 Market share analysis by country
- 5.7 Others
- 5.7.1 Key market trends, growth factors and opportunities
- 5.7.2 Market size and forecast, by region
- 5.7.3 Market share analysis by country
- CHAPTER 6: SILVER WOUND DRESSINGS MARKET, BY END USER
- 6.1 Overview
- 6.1.1 Market size and forecast
- 6.2 Hospitals and Clinics
- 6.2.1 Key market trends, growth factors and opportunities
- 6.2.2 Market size and forecast, by region
- 6.2.3 Market share analysis by country
- 6.3 Ambulatory Surgical Centers
- 6.3.1 Key market trends, growth factors and opportunities
- 6.3.2 Market size and forecast, by region
- 6.3.3 Market share analysis by country
- 6.4 Homecare
- 6.4.1 Key market trends, growth factors and opportunities
- 6.4.2 Market size and forecast, by region
- 6.4.3 Market share analysis by country
- CHAPTER 7: SILVER WOUND DRESSINGS MARKET, BY REGION
- 7.1 Overview
- 7.1.1 Market size and forecast
- 7.2 North America
- 7.2.1 Key trends and opportunities
- 7.2.2 North America Market size and forecast, by Product Type
- 7.2.3 North America Market size and forecast, by Treatment
- 7.2.4 North America Market size and forecast, by End User
- 7.2.5 North America Market size and forecast, by country
- 7.2.5.1 U.S.
- 7.2.5.1.1 Key market trends, growth factors and opportunities
- 7.2.5.1.2 Market size and forecast, by Product Type
- 7.2.5.1.3 Market size and forecast, by Treatment
- 7.2.5.1.4 Market size and forecast, by End User
- 7.2.5.2 Canada
- 7.2.5.2.1 Key market trends, growth factors and opportunities
- 7.2.5.2.2 Market size and forecast, by Product Type
- 7.2.5.2.3 Market size and forecast, by Treatment
- 7.2.5.2.4 Market size and forecast, by End User
- 7.2.5.3 Mexico
- 7.2.5.3.1 Key market trends, growth factors and opportunities
- 7.2.5.3.2 Market size and forecast, by Product Type
- 7.2.5.3.3 Market size and forecast, by Treatment
- 7.2.5.3.4 Market size and forecast, by End User
- 7.3 Europe
- 7.3.1 Key trends and opportunities
- 7.3.2 Europe Market size and forecast, by Product Type
- 7.3.3 Europe Market size and forecast, by Treatment
- 7.3.4 Europe Market size and forecast, by End User
- 7.3.5 Europe Market size and forecast, by country
- 7.3.5.1 Germany
- 7.3.5.1.1 Key market trends, growth factors and opportunities
- 7.3.5.1.2 Market size and forecast, by Product Type
- 7.3.5.1.3 Market size and forecast, by Treatment
- 7.3.5.1.4 Market size and forecast, by End User
- 7.3.5.2 France
- 7.3.5.2.1 Key market trends, growth factors and opportunities
- 7.3.5.2.2 Market size and forecast, by Product Type
- 7.3.5.2.3 Market size and forecast, by Treatment
- 7.3.5.2.4 Market size and forecast, by End User
- 7.3.5.3 UK
- 7.3.5.3.1 Key market trends, growth factors and opportunities
- 7.3.5.3.2 Market size and forecast, by Product Type
- 7.3.5.3.3 Market size and forecast, by Treatment
- 7.3.5.3.4 Market size and forecast, by End User
- 7.3.5.4 Italy
- 7.3.5.4.1 Key market trends, growth factors and opportunities
- 7.3.5.4.2 Market size and forecast, by Product Type
- 7.3.5.4.3 Market size and forecast, by Treatment
- 7.3.5.4.4 Market size and forecast, by End User
- 7.3.5.5 Spain
- 7.3.5.5.1 Key market trends, growth factors and opportunities
- 7.3.5.5.2 Market size and forecast, by Product Type
- 7.3.5.5.3 Market size and forecast, by Treatment
- 7.3.5.5.4 Market size and forecast, by End User
- 7.3.5.6 Rest of Europe
- 7.3.5.6.1 Key market trends, growth factors and opportunities
- 7.3.5.6.2 Market size and forecast, by Product Type
- 7.3.5.6.3 Market size and forecast, by Treatment
- 7.3.5.6.4 Market size and forecast, by End User
- 7.4 Asia-Pacific
- 7.4.1 Key trends and opportunities
- 7.4.2 Asia-Pacific Market size and forecast, by Product Type
- 7.4.3 Asia-Pacific Market size and forecast, by Treatment
- 7.4.4 Asia-Pacific Market size and forecast, by End User
- 7.4.5 Asia-Pacific Market size and forecast, by country
- 7.4.5.1 Japan
- 7.4.5.1.1 Key market trends, growth factors and opportunities
- 7.4.5.1.2 Market size and forecast, by Product Type
- 7.4.5.1.3 Market size and forecast, by Treatment
- 7.4.5.1.4 Market size and forecast, by End User
- 7.4.5.2 China
- 7.4.5.2.1 Key market trends, growth factors and opportunities
- 7.4.5.2.2 Market size and forecast, by Product Type
- 7.4.5.2.3 Market size and forecast, by Treatment
- 7.4.5.2.4 Market size and forecast, by End User
- 7.4.5.3 Australia
- 7.4.5.3.1 Key market trends, growth factors and opportunities
- 7.4.5.3.2 Market size and forecast, by Product Type
- 7.4.5.3.3 Market size and forecast, by Treatment
- 7.4.5.3.4 Market size and forecast, by End User
- 7.4.5.4 India
- 7.4.5.4.1 Key market trends, growth factors and opportunities
- 7.4.5.4.2 Market size and forecast, by Product Type
- 7.4.5.4.3 Market size and forecast, by Treatment
- 7.4.5.4.4 Market size and forecast, by End User
- 7.4.5.5 South Korea
- 7.4.5.5.1 Key market trends, growth factors and opportunities
- 7.4.5.5.2 Market size and forecast, by Product Type
- 7.4.5.5.3 Market size and forecast, by Treatment
- 7.4.5.5.4 Market size and forecast, by End User
- 7.4.5.6 Rest of Asia-Pacific
- 7.4.5.6.1 Key market trends, growth factors and opportunities
- 7.4.5.6.2 Market size and forecast, by Product Type
- 7.4.5.6.3 Market size and forecast, by Treatment
- 7.4.5.6.4 Market size and forecast, by End User
- 7.5 LAMEA
- 7.5.1 Key trends and opportunities
- 7.5.2 LAMEA Market size and forecast, by Product Type
- 7.5.3 LAMEA Market size and forecast, by Treatment
- 7.5.4 LAMEA Market size and forecast, by End User
- 7.5.5 LAMEA Market size and forecast, by country
- 7.5.5.1 Brazil
- 7.5.5.1.1 Key market trends, growth factors and opportunities
- 7.5.5.1.2 Market size and forecast, by Product Type
- 7.5.5.1.3 Market size and forecast, by Treatment
- 7.5.5.1.4 Market size and forecast, by End User
- 7.5.5.2 Saudi Arabia
- 7.5.5.2.1 Key market trends, growth factors and opportunities
- 7.5.5.2.2 Market size and forecast, by Product Type
- 7.5.5.2.3 Market size and forecast, by Treatment
- 7.5.5.2.4 Market size and forecast, by End User
- 7.5.5.3 South Africa
- 7.5.5.3.1 Key market trends, growth factors and opportunities
- 7.5.5.3.2 Market size and forecast, by Product Type
- 7.5.5.3.3 Market size and forecast, by Treatment
- 7.5.5.3.4 Market size and forecast, by End User
- 7.5.5.4 Rest of LAMEA
- 7.5.5.4.1 Key market trends, growth factors and opportunities
- 7.5.5.4.2 Market size and forecast, by Product Type
- 7.5.5.4.3 Market size and forecast, by Treatment
- 7.5.5.4.4 Market size and forecast, by End User
- CHAPTER 8: COMPANY LANDSCAPE
- 8.1. Introduction
- 8.2. Top winning strategies
- 8.3. Product Mapping of Top 10 Player
- 8.4. Competitive Dashboard
- 8.5. Competitive Heatmap
- 8.6. Key developments
- CHAPTER 9: COMPANY PROFILES
- 9.1 3M Company
- 9.1.1 Company overview
- 9.1.2 Company snapshot
- 9.1.3 Operating business segments
- 9.1.4 Product portfolio
- 9.1.5 Business performance
- 9.1.6 Key strategic moves and developments
- 9.2 Argentum Medical LLC
- 9.2.1 Company overview
- 9.2.2 Company snapshot
- 9.2.3 Operating business segments
- 9.2.4 Product portfolio
- 9.2.5 Business performance
- 9.2.6 Key strategic moves and developments
- 9.3 , B Braun Melsungen AG
- 9.3.1 Company overview
- 9.3.2 Company snapshot
- 9.3.3 Operating business segments
- 9.3.4 Product portfolio
- 9.3.5 Business performance
- 9.3.6 Key strategic moves and developments
- 9.4 Convatec, Inc.
- 9.4.1 Company overview
- 9.4.2 Company snapshot
- 9.4.3 Operating business segments
- 9.4.4 Product portfolio
- 9.4.5 Business performance
- 9.4.6 Key strategic moves and developments
- 9.5 Ferris Mfg.Corp
- 9.5.1 Company overview
- 9.5.2 Company snapshot
- 9.5.3 Operating business segments
- 9.5.4 Product portfolio
- 9.5.5 Business performance
- 9.5.6 Key strategic moves and developments
- 9.6 Johnson And Johnson
- 9.6.1 Company overview
- 9.6.2 Company snapshot
- 9.6.3 Operating business segments
- 9.6.4 Product portfolio
- 9.6.5 Business performance
- 9.6.6 Key strategic moves and developments
- 9.7 Monlycke Health Care
- 9.7.1 Company overview
- 9.7.2 Company snapshot
- 9.7.3 Operating business segments
- 9.7.4 Product portfolio
- 9.7.5 Business performance
- 9.7.6 Key strategic moves and developments
- 9.8 Mölnlycke Health Care
- 9.8.1 Company overview
- 9.8.2 Company snapshot
- 9.8.3 Operating business segments
- 9.8.4 Product portfolio
- 9.8.5 Business performance
- 9.8.6 Key strategic moves and developments
- 9.9 medline industries, inc.
- 9.9.1 Company overview
- 9.9.2 Company snapshot
- 9.9.3 Operating business segments
- 9.9.4 Product portfolio
- 9.9.5 Business performance
- 9.9.6 Key strategic moves and developments
- 9.10 DermaRite Industries, LLC.
- 9.10.1 Company overview
- 9.10.2 Company snapshot
- 9.10.3 Operating business segments
- 9.10.4 Product portfolio
- 9.10.5 Business performance
- 9.10.6 Key strategic moves and developments
- LIST OF TABLES
- TABLE 1. GLOBAL SILVER WOUND DRESSINGS MARKET, BY PRODUCT TYPE, 2021-2031 (REVENUE, $MILLION)
- TABLE 2. SILVER WOUND DRESSINGS MARKET FOR SHEETS, BY REGION, 2021-2031 (REVENUE, $MILLION)
- TABLE 3. SILVER WOUND DRESSINGS MARKET FOR SHEETS, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
- TABLE 4. SILVER WOUND DRESSINGS MARKET FOR GELS AND CREAMS, BY REGION, 2021-2031 (REVENUE, $MILLION)
- TABLE 5. SILVER WOUND DRESSINGS MARKET FOR GELS AND CREAMS, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
- TABLE 6. GLOBAL GELS AND CREAMS SILVER WOUND DRESSINGS MARKET, BY TYPE, 2021-2031 (REVENUE, $MILLION)
- TABLE 7. SILVER WOUND DRESSINGS MARKET FOR FOAMS, BY REGION, 2021-2031 (REVENUE, $MILLION)
- TABLE 8. SILVER WOUND DRESSINGS MARKET FOR FOAMS, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
- TABLE 9. SILVER WOUND DRESSINGS MARKET FOR OTHERS, BY REGION, 2021-2031 (REVENUE, $MILLION)
- TABLE 10. SILVER WOUND DRESSINGS MARKET FOR OTHERS, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
- TABLE 11. GLOBAL SILVER WOUND DRESSINGS MARKET, BY TREATMENT, 2021-2031 (REVENUE, $MILLION)
- TABLE 12. SILVER WOUND DRESSINGS MARKET FOR SURGICAL WOUNDS, BY REGION, 2021-2031 (REVENUE, $MILLION)
- TABLE 13. SILVER WOUND DRESSINGS MARKET FOR SURGICAL WOUNDS, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
- TABLE 14. SILVER WOUND DRESSINGS MARKET FOR BURNS, BY REGION, 2021-2031 (REVENUE, $MILLION)
- TABLE 15. SILVER WOUND DRESSINGS MARKET FOR BURNS, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
- TABLE 16. SILVER WOUND DRESSINGS MARKET FOR ULCERS, BY REGION, 2021-2031 (REVENUE, $MILLION)
- TABLE 17. SILVER WOUND DRESSINGS MARKET FOR ULCERS, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
- TABLE 18. SILVER WOUND DRESSINGS MARKET FOR LACERATIONS AND CUTS, BY REGION, 2021-2031 (REVENUE, $MILLION)
- TABLE 19. SILVER WOUND DRESSINGS MARKET FOR LACERATIONS AND CUTS, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
- TABLE 20. SILVER WOUND DRESSINGS MARKET FOR SKIN GRAFTS, BY REGION, 2021-2031 (REVENUE, $MILLION)
- TABLE 21. SILVER WOUND DRESSINGS MARKET FOR SKIN GRAFTS, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
- TABLE 22. SILVER WOUND DRESSINGS MARKET FOR OTHERS, BY REGION, 2021-2031 (REVENUE, $MILLION)
- TABLE 23. SILVER WOUND DRESSINGS MARKET FOR OTHERS, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
- TABLE 24. GLOBAL SILVER WOUND DRESSINGS MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
- TABLE 25. SILVER WOUND DRESSINGS MARKET FOR HOSPITALS AND CLINICS, BY REGION, 2021-2031 (REVENUE, $MILLION)
- TABLE 26. SILVER WOUND DRESSINGS MARKET FOR HOSPITALS AND CLINICS, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
- TABLE 27. SILVER WOUND DRESSINGS MARKET FOR AMBULATORY SURGICAL CENTERS, BY REGION, 2021-2031 (REVENUE, $MILLION)
- TABLE 28. SILVER WOUND DRESSINGS MARKET FOR AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
- TABLE 29. SILVER WOUND DRESSINGS MARKET FOR HOMECARE, BY REGION, 2021-2031 (REVENUE, $MILLION)
- TABLE 30. SILVER WOUND DRESSINGS MARKET FOR HOMECARE, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
- TABLE 31. SILVER WOUND DRESSINGS MARKET, BY REGION, 2021-2031 (REVENUE, $MILLION)
- TABLE 32. NORTH AMERICA SILVER WOUND DRESSINGS MARKET, BY PRODUCT TYPE, 2021-2031 (REVENUE, $MILLION)
- TABLE 33. NORTH AMERICA SILVER WOUND DRESSINGS MARKET, BY TREATMENT, 2021-2031 (REVENUE, $MILLION)
- TABLE 34. NORTH AMERICA SILVER WOUND DRESSINGS MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
- TABLE 35. NORTH AMERICA SILVER WOUND DRESSINGS MARKET, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
- TABLE 36. U.S. SILVER WOUND DRESSINGS MARKET, BY PRODUCT TYPE, 2021-2031 (REVENUE, $MILLION)
- TABLE 37. U.S. SILVER WOUND DRESSINGS MARKET, BY TREATMENT, 2021-2031 (REVENUE, $MILLION)
- TABLE 38. U.S. SILVER WOUND DRESSINGS MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
- TABLE 39. CANADA SILVER WOUND DRESSINGS MARKET, BY PRODUCT TYPE, 2021-2031 (REVENUE, $MILLION)
- TABLE 40. CANADA SILVER WOUND DRESSINGS MARKET, BY TREATMENT, 2021-2031 (REVENUE, $MILLION)
- TABLE 41. CANADA SILVER WOUND DRESSINGS MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
- TABLE 42. MEXICO SILVER WOUND DRESSINGS MARKET, BY PRODUCT TYPE, 2021-2031 (REVENUE, $MILLION)
- TABLE 43. MEXICO SILVER WOUND DRESSINGS MARKET, BY TREATMENT, 2021-2031 (REVENUE, $MILLION)
- TABLE 44. MEXICO SILVER WOUND DRESSINGS MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
- TABLE 45. EUROPE SILVER WOUND DRESSINGS MARKET, BY PRODUCT TYPE, 2021-2031 (REVENUE, $MILLION)
- TABLE 46. EUROPE SILVER WOUND DRESSINGS MARKET, BY TREATMENT, 2021-2031 (REVENUE, $MILLION)
- TABLE 47. EUROPE SILVER WOUND DRESSINGS MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
- TABLE 48. EUROPE SILVER WOUND DRESSINGS MARKET, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
- TABLE 49. GERMANY SILVER WOUND DRESSINGS MARKET, BY PRODUCT TYPE, 2021-2031 (REVENUE, $MILLION)
- TABLE 50. GERMANY SILVER WOUND DRESSINGS MARKET, BY TREATMENT, 2021-2031 (REVENUE, $MILLION)
- TABLE 51. GERMANY SILVER WOUND DRESSINGS MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
- TABLE 52. FRANCE SILVER WOUND DRESSINGS MARKET, BY PRODUCT TYPE, 2021-2031 (REVENUE, $MILLION)
- TABLE 53. FRANCE SILVER WOUND DRESSINGS MARKET, BY TREATMENT, 2021-2031 (REVENUE, $MILLION)
- TABLE 54. FRANCE SILVER WOUND DRESSINGS MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
- TABLE 55. UK SILVER WOUND DRESSINGS MARKET, BY PRODUCT TYPE, 2021-2031 (REVENUE, $MILLION)
- TABLE 56. UK SILVER WOUND DRESSINGS MARKET, BY TREATMENT, 2021-2031 (REVENUE, $MILLION)
- TABLE 57. UK SILVER WOUND DRESSINGS MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
- TABLE 58. ITALY SILVER WOUND DRESSINGS MARKET, BY PRODUCT TYPE, 2021-2031 (REVENUE, $MILLION)
- TABLE 59. ITALY SILVER WOUND DRESSINGS MARKET, BY TREATMENT, 2021-2031 (REVENUE, $MILLION)
- TABLE 60. ITALY SILVER WOUND DRESSINGS MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
- TABLE 61. SPAIN SILVER WOUND DRESSINGS MARKET, BY PRODUCT TYPE, 2021-2031 (REVENUE, $MILLION)
- TABLE 62. SPAIN SILVER WOUND DRESSINGS MARKET, BY TREATMENT, 2021-2031 (REVENUE, $MILLION)
- TABLE 63. SPAIN SILVER WOUND DRESSINGS MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
- TABLE 64. REST OF EUROPE SILVER WOUND DRESSINGS MARKET, BY PRODUCT TYPE, 2021-2031 (REVENUE, $MILLION)
- TABLE 65. REST OF EUROPE SILVER WOUND DRESSINGS MARKET, BY TREATMENT, 2021-2031 (REVENUE, $MILLION)
- TABLE 66. REST OF EUROPE SILVER WOUND DRESSINGS MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
- TABLE 67. ASIA-PACIFIC SILVER WOUND DRESSINGS MARKET, BY PRODUCT TYPE, 2021-2031 (REVENUE, $MILLION)
- TABLE 68. ASIA-PACIFIC SILVER WOUND DRESSINGS MARKET, BY TREATMENT, 2021-2031 (REVENUE, $MILLION)
- TABLE 69. ASIA-PACIFIC SILVER WOUND DRESSINGS MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
- TABLE 70. ASIA-PACIFIC SILVER WOUND DRESSINGS MARKET, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
- TABLE 71. JAPAN SILVER WOUND DRESSINGS MARKET, BY PRODUCT TYPE, 2021-2031 (REVENUE, $MILLION)
- TABLE 72. JAPAN SILVER WOUND DRESSINGS MARKET, BY TREATMENT, 2021-2031 (REVENUE, $MILLION)
- TABLE 73. JAPAN SILVER WOUND DRESSINGS MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
- TABLE 74. CHINA SILVER WOUND DRESSINGS MARKET, BY PRODUCT TYPE, 2021-2031 (REVENUE, $MILLION)
- TABLE 75. CHINA SILVER WOUND DRESSINGS MARKET, BY TREATMENT, 2021-2031 (REVENUE, $MILLION)
- TABLE 76. CHINA SILVER WOUND DRESSINGS MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
- TABLE 77. AUSTRALIA SILVER WOUND DRESSINGS MARKET, BY PRODUCT TYPE, 2021-2031 (REVENUE, $MILLION)
- TABLE 78. AUSTRALIA SILVER WOUND DRESSINGS MARKET, BY TREATMENT, 2021-2031 (REVENUE, $MILLION)
- TABLE 79. AUSTRALIA SILVER WOUND DRESSINGS MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
- TABLE 80. INDIA SILVER WOUND DRESSINGS MARKET, BY PRODUCT TYPE, 2021-2031 (REVENUE, $MILLION)
- TABLE 81. INDIA SILVER WOUND DRESSINGS MARKET, BY TREATMENT, 2021-2031 (REVENUE, $MILLION)
- TABLE 82. INDIA SILVER WOUND DRESSINGS MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
- TABLE 83. SOUTH KOREA SILVER WOUND DRESSINGS MARKET, BY PRODUCT TYPE, 2021-2031 (REVENUE, $MILLION)
- TABLE 84. SOUTH KOREA SILVER WOUND DRESSINGS MARKET, BY TREATMENT, 2021-2031 (REVENUE, $MILLION)
- TABLE 85. SOUTH KOREA SILVER WOUND DRESSINGS MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
- TABLE 86. REST OF ASIA-PACIFIC SILVER WOUND DRESSINGS MARKET, BY PRODUCT TYPE, 2021-2031 (REVENUE, $MILLION)
- TABLE 87. REST OF ASIA-PACIFIC SILVER WOUND DRESSINGS MARKET, BY TREATMENT, 2021-2031 (REVENUE, $MILLION)
- TABLE 88. REST OF ASIA-PACIFIC SILVER WOUND DRESSINGS MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
- TABLE 89. LAMEA SILVER WOUND DRESSINGS MARKET, BY PRODUCT TYPE, 2021-2031 (REVENUE, $MILLION)
- TABLE 90. LAMEA SILVER WOUND DRESSINGS MARKET, BY TREATMENT, 2021-2031 (REVENUE, $MILLION)
- TABLE 91. LAMEA SILVER WOUND DRESSINGS MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
- TABLE 92. LAMEA SILVER WOUND DRESSINGS MARKET, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
- TABLE 93. BRAZIL SILVER WOUND DRESSINGS MARKET, BY PRODUCT TYPE, 2021-2031 (REVENUE, $MILLION)
- TABLE 94. BRAZIL SILVER WOUND DRESSINGS MARKET, BY TREATMENT, 2021-2031 (REVENUE, $MILLION)
- TABLE 95. BRAZIL SILVER WOUND DRESSINGS MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
- TABLE 96. SAUDI ARABIA SILVER WOUND DRESSINGS MARKET, BY PRODUCT TYPE, 2021-2031 (REVENUE, $MILLION)
- TABLE 97. SAUDI ARABIA SILVER WOUND DRESSINGS MARKET, BY TREATMENT, 2021-2031 (REVENUE, $MILLION)
- TABLE 98. SAUDI ARABIA SILVER WOUND DRESSINGS MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
- TABLE 99. SOUTH AFRICA SILVER WOUND DRESSINGS MARKET, BY PRODUCT TYPE, 2021-2031 (REVENUE, $MILLION)
- TABLE 100. SOUTH AFRICA SILVER WOUND DRESSINGS MARKET, BY TREATMENT, 2021-2031 (REVENUE, $MILLION)
- TABLE 101. SOUTH AFRICA SILVER WOUND DRESSINGS MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
- TABLE 102. REST OF LAMEA SILVER WOUND DRESSINGS MARKET, BY PRODUCT TYPE, 2021-2031 (REVENUE, $MILLION)
- TABLE 103. REST OF LAMEA SILVER WOUND DRESSINGS MARKET, BY TREATMENT, 2021-2031 (REVENUE, $MILLION)
- TABLE 104. REST OF LAMEA SILVER WOUND DRESSINGS MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
- TABLE 105.3M COMPANY: COMPANY SNAPSHOT
- TABLE 106.3M COMPANY: OPERATING SEGMENTS
- TABLE 107.3M COMPANY: PRODUCT PORTFOLIO
- TABLE 108.3M COMPANY: NET SALES
- TABLE 109.3M COMPANY: KEY STRATERGIES
- TABLE 110.ARGENTUM MEDICAL LLC: COMPANY SNAPSHOT
- TABLE 111.ARGENTUM MEDICAL LLC: OPERATING SEGMENTS
- TABLE 112.ARGENTUM MEDICAL LLC: PRODUCT PORTFOLIO
- TABLE 113.ARGENTUM MEDICAL LLC: NET SALES
- TABLE 114.ARGENTUM MEDICAL LLC: KEY STRATERGIES
- TABLE 115., B BRAUN MELSUNGEN AG: COMPANY SNAPSHOT
- TABLE 116., B BRAUN MELSUNGEN AG: OPERATING SEGMENTS
- TABLE 117., B BRAUN MELSUNGEN AG: PRODUCT PORTFOLIO
- TABLE 118., B BRAUN MELSUNGEN AG: NET SALES
- TABLE 119., B BRAUN MELSUNGEN AG: KEY STRATERGIES
- TABLE 120.CONVATEC, INC.: COMPANY SNAPSHOT
- TABLE 121.CONVATEC, INC.: OPERATING SEGMENTS
- TABLE 122.CONVATEC, INC.: PRODUCT PORTFOLIO
- TABLE 123.CONVATEC, INC.: NET SALES
- TABLE 124.CONVATEC, INC.: KEY STRATERGIES
- TABLE 125.FERRIS MFG.CORP: COMPANY SNAPSHOT
- TABLE 126.FERRIS MFG.CORP: OPERATING SEGMENTS
- TABLE 127.FERRIS MFG.CORP: PRODUCT PORTFOLIO
- TABLE 128.FERRIS MFG.CORP: NET SALES
- TABLE 129.FERRIS MFG.CORP: KEY STRATERGIES
- TABLE 130.JOHNSON AND JOHNSON: COMPANY SNAPSHOT
- TABLE 131.JOHNSON AND JOHNSON: OPERATING SEGMENTS
- TABLE 132.JOHNSON AND JOHNSON: PRODUCT PORTFOLIO
- TABLE 133.JOHNSON AND JOHNSON: NET SALES
- TABLE 134.JOHNSON AND JOHNSON: KEY STRATERGIES
- TABLE 135.MONLYCKE HEALTH CARE: COMPANY SNAPSHOT
- TABLE 136.MONLYCKE HEALTH CARE: OPERATING SEGMENTS
- TABLE 137.MONLYCKE HEALTH CARE: PRODUCT PORTFOLIO
- TABLE 138.MONLYCKE HEALTH CARE: NET SALES
- TABLE 139.MONLYCKE HEALTH CARE: KEY STRATERGIES
- TABLE 140.MÖLNLYCKE HEALTH CARE: COMPANY SNAPSHOT
- TABLE 141.MÖLNLYCKE HEALTH CARE: OPERATING SEGMENTS
- TABLE 142.MÖLNLYCKE HEALTH CARE: PRODUCT PORTFOLIO
- TABLE 143.MÖLNLYCKE HEALTH CARE: NET SALES
- TABLE 144.MÖLNLYCKE HEALTH CARE: KEY STRATERGIES
- TABLE 145.MEDLINE INDUSTRIES, INC.: COMPANY SNAPSHOT
- TABLE 146.MEDLINE INDUSTRIES, INC.: OPERATING SEGMENTS
- TABLE 147.MEDLINE INDUSTRIES, INC.: PRODUCT PORTFOLIO
- TABLE 148.MEDLINE INDUSTRIES, INC.: NET SALES
- TABLE 149.MEDLINE INDUSTRIES, INC.: KEY STRATERGIES
- TABLE 150.DERMARITE INDUSTRIES, LLC.: COMPANY SNAPSHOT
- TABLE 151.DERMARITE INDUSTRIES, LLC.: OPERATING SEGMENTS
- TABLE 152.DERMARITE INDUSTRIES, LLC.: PRODUCT PORTFOLIO
- TABLE 153.DERMARITE INDUSTRIES, LLC.: NET SALES
- TABLE 154.DERMARITE INDUSTRIES, LLC.: KEY STRATERGIES
- LIST OF FIGURES
- FIGURE 1.SILVER WOUND DRESSINGS MARKET SEGMENTATION
- FIGURE 2.SILVER WOUND DRESSINGS MARKET,2021-2031
- FIGURE 3.SILVER WOUND DRESSINGS MARKET,2021-2031
- FIGURE 4. TOP INVESTMENT POCKETS, BY REGION
- FIGURE 5.PORTER FIVE-1
- FIGURE 6.PORTER FIVE-2
- FIGURE 7.PORTER FIVE-3
- FIGURE 8.PORTER FIVE-4
- FIGURE 9.PORTER FIVE-5
- FIGURE 10.TOP PLAYER POSITIONING
- FIGURE 11.SILVER WOUND DRESSINGS MARKET:DRIVERS, RESTRAINTS AND OPPORTUNITIES
- FIGURE 12.SILVER WOUND DRESSINGS MARKET,BY PRODUCT TYPE,2021(%)
- FIGURE 13.COMPARATIVE SHARE ANALYSIS OF SHEETS SILVER WOUND DRESSINGS MARKET,2021-2031(%)
- FIGURE 14.COMPARATIVE SHARE ANALYSIS OF GELS AND CREAMS SILVER WOUND DRESSINGS MARKET,2021-2031(%)
- FIGURE 15.COMPARATIVE SHARE ANALYSIS OF FOAMS SILVER WOUND DRESSINGS MARKET,2021-2031(%)
- FIGURE 16.COMPARATIVE SHARE ANALYSIS OF OTHERS SILVER WOUND DRESSINGS MARKET,2021-2031(%)
- FIGURE 17.SILVER WOUND DRESSINGS MARKET,BY TREATMENT,2021(%)
- FIGURE 18.COMPARATIVE SHARE ANALYSIS OF SURGICAL WOUNDS SILVER WOUND DRESSINGS MARKET,2021-2031(%)
- FIGURE 19.COMPARATIVE SHARE ANALYSIS OF BURNS SILVER WOUND DRESSINGS MARKET,2021-2031(%)
- FIGURE 20.COMPARATIVE SHARE ANALYSIS OF ULCERS SILVER WOUND DRESSINGS MARKET,2021-2031(%)
- FIGURE 21.COMPARATIVE SHARE ANALYSIS OF LACERATIONS AND CUTS SILVER WOUND DRESSINGS MARKET,2021-2031(%)
- FIGURE 22.COMPARATIVE SHARE ANALYSIS OF SKIN GRAFTS SILVER WOUND DRESSINGS MARKET,2021-2031(%)
- FIGURE 23.COMPARATIVE SHARE ANALYSIS OF OTHERS SILVER WOUND DRESSINGS MARKET,2021-2031(%)
- FIGURE 24.SILVER WOUND DRESSINGS MARKET,BY END USER,2021(%)
- FIGURE 25.COMPARATIVE SHARE ANALYSIS OF HOSPITALS AND CLINICS SILVER WOUND DRESSINGS MARKET,2021-2031(%)
- FIGURE 26.COMPARATIVE SHARE ANALYSIS OF AMBULATORY SURGICAL CENTERS SILVER WOUND DRESSINGS MARKET,2021-2031(%)
- FIGURE 27.COMPARATIVE SHARE ANALYSIS OF HOMECARE SILVER WOUND DRESSINGS MARKET,2021-2031(%)
- FIGURE 28.SILVER WOUND DRESSINGS MARKET BY REGION,2021
- FIGURE 29.U.S. SILVER WOUND DRESSINGS MARKET,2021-2031($MILLION)
- FIGURE 30.CANADA SILVER WOUND DRESSINGS MARKET,2021-2031($MILLION)
- FIGURE 31.MEXICO SILVER WOUND DRESSINGS MARKET,2021-2031($MILLION)
- FIGURE 32.GERMANY SILVER WOUND DRESSINGS MARKET,2021-2031($MILLION)
- FIGURE 33.FRANCE SILVER WOUND DRESSINGS MARKET,2021-2031($MILLION)
- FIGURE 34.UK SILVER WOUND DRESSINGS MARKET,2021-2031($MILLION)
- FIGURE 35.ITALY SILVER WOUND DRESSINGS MARKET,2021-2031($MILLION)
- FIGURE 36.SPAIN SILVER WOUND DRESSINGS MARKET,2021-2031($MILLION)
- FIGURE 37.REST OF EUROPE SILVER WOUND DRESSINGS MARKET,2021-2031($MILLION)
- FIGURE 38.JAPAN SILVER WOUND DRESSINGS MARKET,2021-2031($MILLION)
- FIGURE 39.CHINA SILVER WOUND DRESSINGS MARKET,2021-2031($MILLION)
- FIGURE 40.AUSTRALIA SILVER WOUND DRESSINGS MARKET,2021-2031($MILLION)
- FIGURE 41.INDIA SILVER WOUND DRESSINGS MARKET,2021-2031($MILLION)
- FIGURE 42.SOUTH KOREA SILVER WOUND DRESSINGS MARKET,2021-2031($MILLION)
- FIGURE 43.REST OF ASIA-PACIFIC SILVER WOUND DRESSINGS MARKET,2021-2031($MILLION)
- FIGURE 44.BRAZIL SILVER WOUND DRESSINGS MARKET,2021-2031($MILLION)
- FIGURE 45.SAUDI ARABIA SILVER WOUND DRESSINGS MARKET,2021-2031($MILLION)
- FIGURE 46.SOUTH AFRICA SILVER WOUND DRESSINGS MARKET,2021-2031($MILLION)
- FIGURE 47.REST OF LAMEA SILVER WOUND DRESSINGS MARKET,2021-2031($MILLION)
- FIGURE 48. TOP WINNING STRATEGIES, BY YEAR
- FIGURE 49. TOP WINNING STRATEGIES, BY DEVELOPMENT
- FIGURE 50. TOP WINNING STRATEGIES, BY COMPANY
- FIGURE 51.PRODUCT MAPPING OF TOP 10 PLAYERS
- FIGURE 52.COMPETITIVE DASHBOARD
- FIGURE 53.COMPETITIVE HEATMAP OF TOP 10 KEY PLAYERS
- FIGURE 54.3M COMPANY.: NET SALES ($MILLION)
- FIGURE 55.ARGENTUM MEDICAL LLC.: NET SALES ($MILLION)
- FIGURE 56., B BRAUN MELSUNGEN AG.: NET SALES ($MILLION)
- FIGURE 57.CONVATEC, INC..: NET SALES ($MILLION)
- FIGURE 58.FERRIS MFG.CORP.: NET SALES ($MILLION)
- FIGURE 59.JOHNSON AND JOHNSON.: NET SALES ($MILLION)
- FIGURE 60.MONLYCKE HEALTH CARE.: NET SALES ($MILLION)
- FIGURE 61.MÖLNLYCKE HEALTH CARE.: NET SALES ($MILLION)
- FIGURE 62.MEDLINE INDUSTRIES, INC..: NET SALES ($MILLION)
- FIGURE 63.DERMARITE INDUSTRIES, LLC..: NET SALES ($MILLION)
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook